Group One Trading, L.P. Clovis Oncology, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.63 - $2.96 $10,141 - $47,647	-16,097 Reduced 6.34%	237,835 $428,000
Q1 2022 May 12, 2022	BUY	$1.43 - $3.14 $6,552 - $14,387	4,582 Added 1.84%	253,932 $513,000
Q4 2021 Feb 11, 2022	SELL	$2.7 - $4.76 $228,195 - $402,300	-84,517 Reduced 25.31%	249,350 $676,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $116,554 - $166,506	28,708 Added 9.41%	333,867 $1.49 Million
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $221,492 - $311,060	44,122 Added 16.9%	305,159 $1.77 Million
Q1 2021 May 12, 2021	SELL	$4.81 - $10.34 $327,426 - $703,864	-68,072 Reduced 20.68%	261,037 $1.83 Million
Q4 2020 Feb 10, 2021	BUY	$4.13 - $6.41 $600,047 - $931,308	145,290 Added 79.04%	329,109 $1.58 Million
Q3 2020 Nov 12, 2020	BUY	$4.82 - $7.72 $886,007 - $1.42 Million	183,819 New	183,819 $1.07 Million
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $110,723 - $432,470	-28,174 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$12.81 - $25.67 $201,539 - $403,866	-15,733 Reduced 35.83%	28,174 $419,000
Q1 2019 May 13, 2019	SELL	$17.66 - $30.28 $6,675 - $11,445	-378 Reduced 0.85%	43,907 $1.09 Million
Q4 2018 Feb 06, 2019	BUY	$11.63 - $32.67 $273,084 - $767,124	23,481 Added 112.87%	44,285 $795,000
Q3 2018 Nov 08, 2018	SELL	$29.37 - $49.48 $155,661 - $262,244	-5,300 Reduced 20.3%	20,804 $611,000
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $196,756 - $291,907	-4,678 Reduced 15.2%	26,104 $1.19 Million
Q1 2018 May 11, 2018	BUY	$50.12 - $67.72 $229,850 - $310,563	4,586 Added 17.51%	30,782 $1.63 Million
Q4 2017 Feb 09, 2018	SELL	$57.69 - $84.58 $4.57 Million - $6.7 Million	-79,204 Reduced 75.15%	26,196 $1.78 Million
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $1.32 Million - $1.66 Million	19,589 Added 22.83%	105,400 $8.69 Million
Q2 2017 Aug 14, 2017	BUY	N/A	85,811	85,811 $8.03 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account